These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 30099960)

  • 1. Regulation of birthweight by placenta-derived miRNAs: evidence from an arsenic-exposed birth cohort in Bangladesh.
    Rahman ML; Liang L; Valeri L; Su L; Zhu Z; Gao S; Mostofa G; Qamruzzaman Q; Hauser R; Baccarelli A; Christiani DC
    Epigenetics; 2018; 13(6):573-590. PubMed ID: 30099960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation mediates the effect of maternal smoking on offspring birthweight: a birth cohort study of multi-ethnic US mother-newborn pairs.
    Xu R; Hong X; Zhang B; Huang W; Hou W; Wang G; Wang X; Igusa T; Liang L; Ji H
    Clin Epigenetics; 2021 Mar; 13(1):47. PubMed ID: 33663600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating causal relation between prenatal arsenic exposure and birthweight: Are smaller infants more susceptible?
    Rahman ML; Valeri L; Kile ML; Mazumdar M; Mostofa G; Qamruzzaman Q; Rahman M; Baccarelli A; Liang L; Hauser R; Christiani DC
    Environ Int; 2017 Nov; 108():32-40. PubMed ID: 28787626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered Expression of miR-518b and miR-519a in the placenta is associated with low fetal birth weight.
    Wang D; Na Q; Song WW; Song GY
    Am J Perinatol; 2014 Oct; 31(9):729-34. PubMed ID: 24683074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptome-wide analysis of changes in the fetal placenta associated with prenatal arsenic exposure in the New Hampshire Birth Cohort Study.
    Winterbottom EF; Ban Y; Sun X; Capobianco AJ; Marsit CJ; Chen X; Wang L; Karagas MR; Robbins DJ
    Environ Health; 2019 Nov; 18(1):100. PubMed ID: 31752878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placental microRNAs relate to early childhood growth trajectories.
    Kennedy EM; Hermetz K; Burt A; Pei D; Koestler DC; Hao K; Chen J; Gilbert-Diamond D; Ramakrishnan U; Karagas MR; Marsit CJ
    Pediatr Res; 2023 Jul; 94(1):341-348. PubMed ID: 36380070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential miR-346 and miR-582-3p Expression in Association with Selected Maternal and Fetal Complications.
    Tsai PY; Li SH; Chen WN; Tsai HL; Su MT
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28753968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of placenta-specific microRNAs in fetal growth restriction pregnancy.
    Higashijima A; Miura K; Mishima H; Kinoshita A; Jo O; Abe S; Hasegawa Y; Miura S; Yamasaki K; Yoshida A; Yoshiura K; Masuzaki H
    Prenat Diagn; 2013 Mar; 33(3):214-22. PubMed ID: 23354729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cord blood DNA methylation of DNMT3A mediates the association between in utero arsenic exposure and birth outcomes: Results from a prospective birth cohort in Bangladesh.
    Bozack AK; Cardenas A; Geldhof J; Quamruzzaman Q; Rahman M; Mostofa G; Christiani DC; Kile ML
    Environ Res; 2020 Apr; 183():109134. PubMed ID: 32018205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexually dimorphic patterns in maternal circulating microRNAs in pregnancies complicated by fetal growth restriction.
    Baker BC; Lui S; Lorne I; Heazell AEP; Forbes K; Jones RL
    Biol Sex Differ; 2021 Nov; 12(1):61. PubMed ID: 34789323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal blood arsenic levels and associations with birth weight-for-gestational age.
    Mullin AM; Amarasiriwardena C; Cantoral-Preciado A; Claus Henn B; Leon Hsu HH; Sanders AP; Svensson K; Tamayo-Ortiz M; Téllez-Rojo MM; Wright RO; Burris HH
    Environ Res; 2019 Oct; 177():108603. PubMed ID: 31357156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First trimester prediction models for small-for- gestational age and fetal growth restricted fetuses without the presence of preeclampsia.
    Hromadnikova I; Kotlabova K; Krofta L
    Mol Cell Probes; 2023 Dec; 72():101941. PubMed ID: 37951512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex-specific associations between telomere length and candidate miRNA expression in placenta.
    Tsamou M; Martens DS; Cox B; Madhloum N; Vrijens K; Nawrot TS
    J Transl Med; 2018 Sep; 16(1):254. PubMed ID: 30208911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between in utero exposure to polybrominated diphenyl ethers, pathophysiological state of fetal growth and placental DNA methylation changes.
    Zhao Y; Song Q; Ge W; Jin Y; Chen S; Zhao Y; Xiao X; Zhang Y
    Environ Int; 2019 Dec; 133(Pt B):105255. PubMed ID: 31655276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second trimester extracellular microRNAs in maternal blood and fetal growth: An exploratory study.
    Rodosthenous RS; Burris HH; Sanders AP; Just AC; Dereix AE; Svensson K; Solano M; Téllez-Rojo MM; Wright RO; Baccarelli AA
    Epigenetics; 2017 Sep; 12(9):804-810. PubMed ID: 28758828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the human placental (pro)renin receptor-prorenin-angiotensin system by microRNAs.
    Wang Y; Lumbers ER; Arthurs AL; Corbisier de Meaultsart C; Mathe A; Avery-Kiejda KA; Roberts CT; Pipkin FB; Marques FZ; Morris BJ; Pringle KG
    Mol Hum Reprod; 2018 Sep; 24(9):453-464. PubMed ID: 30060096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of customization and use of a fetal growth standard on the association between birthweight percentile and adverse perinatal outcome.
    Sovio U; Smith GCS
    Am J Obstet Gynecol; 2018 Feb; 218(2S):S738-S744. PubMed ID: 29199029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trimester-specific associations between extracellular vesicle microRNAs and fetal growth.
    Fudono A; Imai C; Takimoto H; Tarui I; Aoyama T; Yago S; Okamitsu M; Muramatsu M; Sato N; Miyasaka N
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):8728-8734. PubMed ID: 34779347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal vascular malformation in the placenta is an indicator for fetal growth restriction irrespective of neonatal birthweight.
    Hendrix MLE; Bons JAP; Alers NO; Severens-Rijvers CAH; Spaanderman MEA; Al-Nasiry S
    Placenta; 2019 Nov; 87():8-15. PubMed ID: 31520871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal diabetes alters microRNA expression in fetal exosomes, human umbilical vein endothelial cells and placenta.
    Shah KB; Chernausek SD; Teague AM; Bard DE; Tryggestad JB
    Pediatr Res; 2021 Apr; 89(5):1157-1163. PubMed ID: 32663836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.